APA (7th ed.) Citation

E, B., KE, C., S, G., M, M., C, P., LJ, S., & S, O. (2026). Biosimilar use in medical oncology in Ireland: A missed opportunity to mitigate financial toxicity? International journal of clinical pharmacy. https://doi.org/10.1007/s11096-026-02192-2

Chicago Style (17th ed.) Citation

E, Burton, Coakley KE, Gaynor S, McDonagh M, Palmer C, Sahm LJ, and O'Reilly S. "Biosimilar Use in Medical Oncology in Ireland: A Missed Opportunity to Mitigate Financial Toxicity?" International Journal of Clinical Pharmacy 2026. https://doi.org/10.1007/s11096-026-02192-2.

MLA (9th ed.) Citation

E, Burton, et al. "Biosimilar Use in Medical Oncology in Ireland: A Missed Opportunity to Mitigate Financial Toxicity?" International Journal of Clinical Pharmacy, 2026, https://doi.org/10.1007/s11096-026-02192-2.